Co-founded by C Cheng Holdings Limited, PanMediso Holdings Limited (UK) and Mark Wong & Associates Limited, PanMediso Holdings (Shenzhen) Limited is an international company dedicated to the research, development and production of medical isotopes, particularly Ac-225 and Ge-68.
Gathering top talents in the field of isotopes from both China and the United Kingdom as our core technical team and management, PanMediso Holdings is committed to building a global ecosystem of industry, academia, research, diagnosis and treatment for nuclear medicine and establishing world-class preparation & production centers of medical isotope, to realize the GMP-grade production and global supply of new-type isotopes, thereby bringing new power to the development of human health.
Contact us: alice@panmedisoholdings.com
Company Details
- Founded
- -
- Address
- Changfujinmaobuilding Shihuardfutian Freetradezone Shenzhen 518038 China, Changfujinmaobuilding Shihuardfutian Freetradezone Shenzhen,china
- Industry
- Medical And Diagnostic Laboratories
- NAICS
-
Medical and Diagnostic LaboratoriesMedical LaboratoriesDiagnostic Imaging Centers
- Website
- http://www.panmedisoholdings.com
- Keywords
- meidical, Medical Lab, Medical Service, Medical & health, Nuclear Medicine, Radiopharmaceuticals.
- HQ
- Shenzhen, Guangdong
Panmediso Holdings Questions
Panmediso Holdings's website is http://www.panmedisoholdings.com
Panmediso Holdings's LinkedIn profile is https://cn.linkedin.com/company/panmediso-holdings
Panmediso Holdings's industry is
Medical and Diagnostic Laboratories
Panmediso Holdings's top competitors are
Thermo Fisher Scientific,
Polimaster – Americas,
安然纳米集团,
Panmediso Investments Ltd,
Xyantyx Ltd,
深圳市格物致欣化学技术有限公司,
비약 (Beyond Pharmacist),
昂纳科技有限公司,
重庆睿盟科技有限公司,
Unifying Physics.
Panmediso Holdings's categories are Medical and Diagnostic Laboratories
Panmediso Holdings's founding year is 2023
